AYURCANN REPORTS FISCAL YEAR 2025 RECORD SALES OF $55,446,352 IN GROSS REVENUE, FEATURING 21% YEAR-OVER-YEAR INCREASE AND PROVIDES CORPORATE UPDATE

 AYURCANN REPORTS FISCAL YEAR 2025 RECORD SALES OF $55,446,352 IN GROSS REVENUE, FEATURING 21% YEAR-OVER-YEAR INCREASE AND PROVIDES CORPORATE UPDATE

Toronto, Ontario, Oct. 28, 2025 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE: AYUR; OTCQB: AYURF) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, is pleased to announce i…

Our continued success is rooted in innovation, reliability, and our ability to anticipate market needs, added Sudman. With a clear vision and commitment to excellence, Ayurcann remains focused on dri…